Global Health Diplomacy Commission Reports and Results from the 67 th World Health Assembly Webinar, 26 May 2014

Series of reports timed for or around WHA 67 Growing complexity of global health actors Growing engagement with WHA Close to 3500 official delegates at 67 th session Record-breaking number of agenda items, documents and resolutions Over 20 resolutions adopted, 19 to 24 May 2014

Webinar Agenda, 26 May 2014 Commission reports on global health diplomacy Lancet Commission on Investing in Health University of Oslo on Global Governance for Health Chatham House reports on governance and financing World Health Assembly outcomes of interest Global governance opportunities Health systems and surveillance issues

Lancet Commission Larry Summers and 25 global experts Updating the message of WDR 1993 Key messages of new report Enormous payoffs from investing in health Grand convergence is possible for all countries Fiscal policies are a powerful and underutilized lever for curbing NCDs and injurites Progressive universalism (universal health coverage) is efficient

University of Oslo The political origins of health inequity o Economic crises and austerity measures, o Knowledge and intellectual property, o Foreign investment treaties, o Food security, o Transnational corporate activity, o Irregular migration, and o Violent conflict

Chatham House Reports Governance of WHO Functions and global role of WHO Regional and country offices Financing of the WHO Sustainable health financing Emphasis on domestic financing Global public goods and role of external financing Global agreement on sustainable financing

Webinar Agenda, 26 May 2014 Commission reports on global health diplomacy Lancet Commission on Investing in Health University of Oslo on Global Governance for Health Chatham House reports on governance and financing World Health Assembly outcomes of interest Global governance opportunities Health systems and surveillance issues

WHA Global Governance Opportunities WHO reform on nonstate actors NCD package Post 2015 Development Agenda Nutrition issues

WHA Global Governance Opportunities WHO reform on nonstate actors NCD package Post 2015 Development Agenda Nutrition issues

WHA Global Governance Opportunities Nonstate Actors Framework of Engagement A67/6 Basic principles and categories of interactions Four separate policies and operational procedures Requests for clarity and details on conflict of interest and financing Drafting group revised decision 17 June follow-up questions and DG report Regional committees separate reports Second report from DG to Executive Board

WHA Global Governance Opportunities: NCD Package Commission on Childhood Obesity Nine indicators for Global Action Plan TOR for Inter-Agency Task Force TOR for Global Coordinating Mechanism Limited participation by non-State actors Further work plan limits for Working Groups UN General Assembly Summit 10 to 11 July 2014

WHA Global Governance Opportunities: Post 2015 Agenda Expanding on MDGs for sustainable development (NCDs, mental health, newborn health, injuries) Highest attainable standard of physical and mental health/universal health coverage Strengthening of health systems Health information systems Indicators in all relevant related dimensions

WHA Global Governance Opportunities: Nutrition Maternal, infant and young child nutrition strategy Breast milk substitutes Inappropriate marketing of complementary foods ICN2 – priorities to reshape the food system to respond to health needs WHO new report on nutrition Sept 2014

Webinar Agenda, 26 May 2014 Commission reports on global health diplomacy Lancet Commission on Investing in Health University of Oslo on Global Governance for Health Chatham House reports on governance and financing World Health Assembly outcomes of interest Global governance opportunities Health systems and surveillance issues

Health Systems and Surveillance Consultative Expert Working Group Access to essential medicines Regulatory system strengthening Global Health Security Agenda Antimicrobial resistance

Consultative Expert Working Group Promoting innovative components Leishmaniasis with both DNDi and US FDA Pathogen box for drug development – MMV Biomarkers as diagnostics Voluntary pooled fund through TDR Type I access plus Types II and III diseases Delinkage as the rallying cry

Access to essential medicines Developing a limited range of essential medicines based on best evidence Efficient procurement Affordable prices Effective distribution systems Rational use Referral to core WHO essential medicines list

Regulatory system strengthening Supporting national regulators Quality, safety and efficacy of products Manufactured, stored, distributed and dispensed; Illegal manufacturing & trade controlled & prevented; Rational use by health professionals and public Promotion and advertising is regulated and fair; Access to medicines is not hindered by unjustified regulatory work.Consultative Expert Working Group

Regulatory system strengthening Strengthening of collaboration WHO norms, standards, capacity building Networks of strengthened regulatory authorities and Progressive transition of prequalification

Global Health Security Agenda Launched in February 2014 Concerns: MERS, polio, TB, influenza, anti- microbial resistance Prevention, detection and response Financial commitment development meeting High-level meeting in September

Global Health Security Agenda Integrating health, security, economics, agriculture, humanitarian and diplomatic approaches CDC working with 10 countries Additional 30 countries to advance key milestones $4 billion over 5 years

Antimicrobial resistance Basic priorities: Information and extent of resistance and use in humans and animals Increasing awareness of health providers and public Responsible use and hand hygiene Global action plan for WHA in 2015: improving drug management systems, increasing lifespan of drugs and new diagnostics and drugs

Webinar, 26 May 2014 Q&A Thank You